NOVOCARE
LIVE

Serial Number

79440839

Owner

Novo Nordisk A/S

Filing Date

Nov 6, 2025

Add to watchlist:

No watchlists yet
View on USPTO

NOVOCARE Trademark

Serial Number: 79440839

NOVOCARE is a trademark filed by Novo Nordisk A/S on November 6, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Novo Nordisk A/S (12 trademarks)

Novo Alllé

Entity Type: 65

Trademark Details

Filing Date

November 6, 2025

Registration Date

Not Registered

Goods & Services

Downloadable software in mobile applications for telehealth and telemedicine offerings for use by patients and healthcare professionals; downloadable software from websites for use by patients and healthcare professionals for the treatment of medical conditions; downloadable software for enabling patients to access general medical, health, and wellness information and advice; downloadable software for management and dispensing of medical prescriptions.

Providing information in the field of management of medical conditions; charitable services, namely, patient assistance program to provide pharmaceuticals free of charge to low-income patients without prescription drug coverage.

Providing financial assistance to patients and healthcare providers for prescription pharmaceutical costs; providing information about patient reimbursement and insurance coverage for pharmaceuticals.

Educational services, namely, educational programmes, online electronic publication of reports, newsletters, and articles, online coaching and training services for patients and healthcare professionals related to the treatment of medical conditions.

Promoting public awareness about medical conditions; online business services in the nature of retail pharmacy services for the ordering, purchase, and delivery of pharmaceutical preparations, location of healthcare professional, coordination of direct-to-consumer delivery of medicine.

Instructional and teaching material.

Platform as a service featuring computer software to permit users to identify, request and receive pharmacy products.

Pharmaceutical preparations for the treatment of diabetes and obesity, pharmaceutical preparations for haemostasis management and for the treatment of sickle cell disease; pharmaceutical preparations for the treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease; pharmaceutical preparations for hormone therapy and stem cells for medical purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; chemical preparations for medical use.

Filing History

REFUSAL PROCESSED BY IB
Apr 30, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 13, 2026 RFCS
REFUSAL PROCESSED BY MPU
Apr 13, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 7, 2026 RFCR
NON-FINAL ACTION WRITTEN
Mar 6, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 3, 2026 DOCK
LIMITATION OF GOODS RECEIVED FROM IB
Jan 15, 2026 LIMG
APPLICATION FILING RECEIPT MAILED
Jan 2, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 2, 2026 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jan 1, 2026 SDRC